Access cutting-edge fibrodysplasia ossificans progressiva treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access fibrodysplasia ossificans progressiva specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related fibrodysplasia ossificans progressiva treatment provided free
This study is researching an experimental drug called andecaliximab. The study will include pediatric and adult patients with fibrodysplasia ossificans progressiva (FOP). The study will evaluate how safe and effective andecaliximab is in patients with FOP. The study is looking at several research questions, including: * Safety of andecaliximab in participants with FOP * Whether andecaliximab reduces the number of new heterotopic bone lesions (Heterotopic Ossification; HO) * Whether andecalixim
Sponsor: Ashibio Inc
Check if you qualify for this fibrodysplasia ossificans progressiva clinical trial in Philadelphia, PA
If you're searching for fibrodysplasia ossificans progressiva treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced fibrodysplasia ossificans progressiva specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.